share_log

3 Stocks Under $2 Insiders Are Buying

Benzinga Real-time News ·  May 11, 2022 20:14

US crude oil futures traded higher on Wednesday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

TRACON Pharmaceuticals

  • The Trade: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) President and CEO Charles Theuer acquired a total of 2,500 shares at an average price of $1.97. To acquire these shares, it cost $4.92 thousand.
  • What's Happening: The company is expected to release quarterly earnings after the closing bell today.
  • What TRACON Pharmaceuticals Does: TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States.

Compass Therapeutics

  • The Trade: Compass Therapeutics, Inc. (NASDAQ:CMPX) CEO Thomas J Schuetz acquired a total of 27,836 shares at an average price of $1.80. The insider spent around $50.1 thousand to buy those shares.
  • What's Happening: Compass Therapeutics posted a Q1 loss of $0.07 per share.
  • What Compass Therapeutics Does: Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies.

Also check this: Executives Buy More Than $90M Of 4 Stocks

Don't forget to check out our premarket coverage here .

Invesco Mortgage Capital

  • The Trade: Invesco Mortgage Capital Inc. (NYSE:IVR) President Kevin Collins acquired a total of 7,178 shares at an average price of $1.67. To acquire these shares, it cost around $11.99 thousand.
  • What's Happening: The company recently posted upbeat quarterly earnings.
  • What Invesco Mortgage Capital Does: Invesco Mortgage Capital Inc is an REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment